Atlas Trials

Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis

Clinical trial NCT03692299 · COMPLETED

Trial details

NCT number
NCT03692299
Sponsor
Coordinación de Investigación en Salud, Mexico
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Systemic SclerosisSmall Intestinal Bacterial Overgrowth
Start date
2015-06-01
Primary completion
2019-07-26
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.